(Q34727875)

4 August 2017

Optimal treatment of adrenocortical carcinoma with mitotane: results in a consecutive series of 96 patients (English)

1 reference

4 August 2017

1 reference

adrenocortical carcinoma

1 reference

Haak HR

1

1 reference

4 August 2017

Hermans J

2

1 reference

4 August 2017

van de Velde CJ

3

1 reference

4 August 2017

Lentjes EG

4

1 reference

4 August 2017

Goslings BM

5

1 reference

4 August 2017

Fleuren GJ

6

1 reference

4 August 2017

Krans HM

7

1 reference

4 August 2017

language of work or name

English

0 references

publication date

1 May 1994

1 reference

British Journal of Cancer

4 August 2017

1 reference

4 August 2017

69

1 reference

4 August 2017

5

1 reference

4 August 2017

947-951

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1994.183

4 August 2017

0 references

cites work

CLINICAL AND PATHOPHYSIOLOGIC ASPECTS OF ADRENOCORTICAL CARCINOMA.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968906

Cancer of the adrenal cortex; the natural history, prognosis and treatment in a study of fifty-five cases

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968906

Blood levels of o,p′-DDD following administration in various vehicles after a single dose and during long-term treatment

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968906

Adrenal cortical carcinoma. Results of treatment with o,p'DDD in 138 patients

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968906

Adrenal cortical carcinoma. Clinical features of 138 patients

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968906

Mitotane Use in Inoperable Adrenal Cortical Carcinoma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968906

Mitotane therapy of adrenocortical carcinoma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968906

Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968906

Mitotane increases the blood levels of hormone-binding proteins

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968906

Theory and application of early systemic therapy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968906

o,p'DDD Therapy in Invasive Adrenocortical Carcinoma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968906

Estimation of o,p'-DDD in plasma by gas-liquid chromatography

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968906

The treatment of adrenocortical carcinoma with o,p'-DDD: prognostic implications of serum level monitoring

7 July 2018

1 reference

12 December 2020

Treatment of metastatic adrenal cortical carcinoma with cisplatin and etoposide (VP-16)

1 reference

12 December 2020

Treatment of hormone-producing adrenocortical cancer with o,p'DDD and streptozocin

1 reference

12 December 2020

Adrenal cortical carcinoma

1 reference

12 December 2020

Adrenal cortical carcinoma

1 reference

12 December 2020

Metastatic adrenal cortical carcinoma. Prolonged regression with mitotane therapy

1 reference

12 December 2020

Clinical and laboratory findings and results of therapy in 58 patients with adrenocortical tumors admitted to a single medical center (1951 to 1978)

1 reference

12 December 2020

CAP (cyclophosphamide, doxorubicin, and cisplatin) regimen in adrenal cortical carcinoma

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1994.183

1 reference

Dimensions Publication ID

4 August 2017

0 references

1 reference

4 August 2017

1 reference